Literature DB >> 18711176

Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.

James R Anderson1, Kevin C Cain, Richard D Gelber.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18711176     DOI： 10.1200/JCO.2008.16.1000

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  81 in total

1.  Primary endpoints in cancer trials.

Authors:  Kurt Ulm
Journal:  J Thorac Dis       Date:  2011-06       Impact factor: 2.895

2.  Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Mouhammed A Habra; Thereasa Rich; Paxton V Dickson; Nancy Perrier; Alexandria Phan; Steven Waguespack; Shreyaskumar Patel; Camilo Jimenez
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

3.  Challenges of guarantee-time bias.

Authors:  Anita Giobbie-Hurder; Richard D Gelber; Meredith M Regan
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

4.  Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.

Authors:  Apostolia-Maria Tsimberidou; Sijin Wen; David S Hong; Jennifer J Wheler; Gerald S Falchook; Siqing Fu; Sarina Piha-Paul; Aung Naing; Filip Janku; Kenneth Aldape; Yang Ye; Razelle Kurzrock; Donald Berry
Journal:  Clin Cancer Res       Date:  2014-07-01       Impact factor: 12.531

5.  Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.

Authors:  Anders Österborg; Roxanne C Jewell; Swami Padmanabhan-Iyer; Thomas J Kipps; Jiří Mayer; Stephan Stilgenbauer; Cathy D Williams; Andrzej Hellmann; Richard R Furman; Tadeusz Robak; Peter Hillmen; Marek Trnêný; Martin J S Dyer; Magdalena Piotrowska; Tomas Kozak; Ira V Gupta; Jennifer L Phillips; Nancy Goldstein; Herbert Struemper; Nedjad Losic; Steen Lisby; William G Wierda
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

6.  Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy.

Authors:  Chikako Suzuki; Lennart Blomqvist; Thomas Hatschek; Lena Carlsson; Zakaria Einbeigi; Barbro Linderholm; Birgitta Lindh; Niklas Loman; Martin Malmberg; Samuel Rotstein; Martin Söderberg; Marie Sundqvist; Thomas M Walz; Gunnar Aström; Hirofumi Fujii; Hans Jacobsson; Bengt Glimelius
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

7.  A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.

Authors:  Steven D Gore; Pierre Fenaux; Valeria Santini; John M Bennett; Lewis R Silverman; John F Seymour; Eva Hellström-Lindberg; Arlene S Swern; Charles L Beach; Alan F List
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

8.  A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma.

Authors:  Richard D Carvajal; Michael K Wong; John A Thompson; Michael S Gordon; Karl D Lewis; Anna C Pavlick; Jedd D Wolchok; Patrick B Rojas; Jonathan D Schwartz; Agop Y Bedikian
Journal:  Eur J Cancer       Date:  2014-06-12       Impact factor: 9.162

9.  ¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Authors:  Pierre-Yves Salaun; Loïc Campion; Catherine Ansquer; Eric Frampas; Cédric Mathieu; Philippe Robin; Claire Bournaud; Jean-Philippe Vuillez; David Taieb; Caroline Rousseau; Delphine Drui; Eric Mirallié; Françoise Borson-Chazot; David M Goldenberg; Jean-François Chatal; Jacques Barbet; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-08       Impact factor: 9.236

10.  Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.

Authors:  Daniel Fuerst; Carlheinz Mueller; Dietrich W Beelen; Christine Neuchel; Chrysanthi Tsamadou; Hubert Schrezenmeier; Joannis Mytilineos
Journal:  Haematologica       Date:  2015-11-26       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.